Most people begin at lower doses and increase at intervals set by your prescriber, commonly about every 4 weeks until they reach their therapeutic dose, the level where weight loss becomes consistent and side effects feel manageable
SGLT2 inhibitorrelated adverse effects, including genital mycotic infections, volume depletion, and rarely ketoacidosis, remain clinically relevant and should be considered when these agents are prescribed as part of combination therapy and importantly, the intrinsic risk of hypoglycemia with combined GLP-1 receptor agonist and SGLT2 inhibitor therapy is low because neither class directly stimulates insulin secretion in a glucose-independent manner and when hypoglycemia occurs, it is more commonly related to concomitant insulin or sulfonylurea use rather than the combination itself [41, 42, 44]
That distinction is central to longevity medicine
At the same time, Vitamin B12 remains popular in energy-focused wellness routines because it supports normal cellular energy processes
Consent to publication All authors have read and approved the final version of the manuscript and consent to its publication
